Skip to content

A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralasertib with these medications in adults with advanced solid tumors

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516611-24-00
Acronym
D533BC00003
Enrollment
18
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumour

Interventions

None listed

Sponsors

AstraZeneca AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026